Lv2
106 积分 2021-11-15 加入
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
5小时前
待确认
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
5小时前
已完结
OA11.04 Volrustomig + platinum doublet chemotherapy (CTx) in first-line non-small cell lung cancer (NSCLC): Phase 1b trial update
6天前
已完结
1323P RATIONALE-307 long-term outcomes: First-line tislelizumab (TIS) plus chemotherapy (chemo) vs chemo alone for advanced squamous (sq) NSCLC
6天前
已完结
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
7天前
已完结
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
7天前
已完结
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407
7天前
已完结
1322P A phase II trial of autologous cytokine-induced killer (CIK) therapy plus toripalimab with or without chemotherapy as first-line treatment in advance NSCLC
7天前
已完结
A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)
9天前
已完结
Pembrolizumab for Treatment of Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
14天前
已关闭
皖公网安备34019202002308
